z-logo
open-access-imgOpen Access
Process, resource and success factors associated with chimeric antigen receptor T-cell therapy for multiple myeloma
Author(s) -
Daanish Hoda,
Robert H. Richards,
Edward A. Faber,
Abhinav Deol,
Bradley D. Hunter,
Elizabeth Weber,
Heather DiFilippo,
Toni Henderson-Clark,
Linda Meaux,
Concetta Crivera,
Carrie Riccobono,
Ashraf Garrett,
Carolyn C. Jackson,
Jessica Fowler,
Panteli Theocharous,
R Stewart,
Andrea L. Lorden,
David L. Porter,
Ariel Berger
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0162
Subject(s) - chimeric antigen receptor , medicine , multiple myeloma , reimbursement , health care , car t cell therapy , immunotherapy , cancer , economics , economic growth

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom